DeepMed Research

The Christie NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Established: 2007-01-01

Employees: -

Market Cap: -

Website: http://www.christie.nhs.uk/

Clinical Trials

A Pilot Study Using Magnetic Resonance (MR) to Assess Cervix Motion During Radiotherapy Treatment.

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Other: MR scans

First Posted Date: 2017-04-05

Last Posted Date: 2019-08-02

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 20

Registration Number: NCT03101306

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Other: MRI scan

First Posted Date: 2017-02-09

Last Posted Date: 2019-07-08

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 30

Registration Number: NCT03048760

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer

Early Phase 1

Completed

Conditions: Ovarian Cancer

Interventions: Drug: Olaparib
Drug: Cediranib
Drug: Platinum-based Chemotherapy

First Posted Date: 2016-08-04

Last Posted Date: 2022-02-22

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 28

Registration Number: NCT02855697

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs)

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Counselling
Other: Patient diary PROMs

First Posted Date: 2015-07-24

Last Posted Date: 2023-02-22

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 64

Registration Number: NCT02507804

Locations: 🇬🇧
Christie NHS Foundation Trust, Manchester, United Kingdom

Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer

Completed

Conditions: Metastatic Castration Resistant Prostate Cancer

Interventions: Procedure: Biopsies, blood and urine samples

First Posted Date: 2015-04-23

Last Posted Date: 2016-07-26

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 6

Registration Number: NCT02424448

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers

Phase 1

Completed

Conditions: Biliary Tract Cancer
Gallbladder Cancer
Cholangiocarcinoma
Ampullary Cancer

Interventions: Drug: Acelarin
Drug: Cisplatin

First Posted Date: 2015-01-30

Last Posted Date: 2023-05-17

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 21

Registration Number: NCT02351765

Locations: 🇬🇧
Beatson Oncology Centre, Glasgow, United Kingdom
🇬🇧
Clatterbridge Cancer Centre, Liverpool, United Kingdom
🇬🇧
Imperial College London, London, United Kingdom

and more 2 locations

Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma

Phase 2

Completed

Conditions: Breast Cancer
Multiple Myeloma
Gastrointestinal Cancer
Gynaecological Cancer

Interventions: Procedure: Acupuncture
Other: Medication taken to manage the symptom burden of CIPN

First Posted Date: 2014-10-27

Last Posted Date: 2019-01-31

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 120

Registration Number: NCT02275403

Locations: 🇬🇧
The Royal Oldham Hospital, Oldham, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer

Withdrawn

Conditions: Squamous Cell Carcinoma of the Anus

Interventions: Procedure: Sentinel lymph node biopsy

First Posted Date: 2014-06-13

Last Posted Date: 2015-06-03

Lead Sponsor: The Christie NHS Foundation Trust

Registration Number: NCT02162641

PLX3397 KIT in Acral aNd mucOsal Melanoma

Phase 2

Completed

Conditions: Malignant Melanoma

Interventions: Drug: PLX3397

First Posted Date: 2014-02-26

Last Posted Date: 2021-08-12

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 7

Registration Number: NCT02071940

Locations: 🇬🇧
The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
🇬🇧
Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Swansea, Wales, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

and more 5 locations

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer

Phase 1

Terminated

Conditions: Neoplasms, Ovarian
Ovarian Neoplasms
Ovarian Cancer

Interventions: Drug: Pazopanib
Drug: Fosbretabulin

First Posted Date: 2014-02-05

Last Posted Date: 2021-05-17

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 21

Registration Number: NCT02055690

Locations: 🇬🇧
University Collage London Hospitals NHS Foundation Trust, London, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
🇬🇧
Freeman Hospital (Newcastle-upon-Tyne Hospitals NHS Foundation Trust), Newcastle Upon Tyne, United Kingdom

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy